Here’s who’s eligible and what to consider before deciding.
Articles on Overdiagnosis
Displaying 1 - 20 of 95 articles
PSA testing hasn’t been banned – but the row over prostate cancer screening reveals a genuine scientific and ethical dilemma.
When celebrities go public with their prostate cancer diagnoses, they do more than raise awareness.
Prescriptions for ADHD have grown 11-fold in 20 years. As GPs begin to prescribe ADHD medication, will this rise again?
Modern screening can create patients out of people who never needed treatment in the first place.
Diagnosis rates are rising because the NHS pathway is overwhelmed and fragmented, not because distress is being exaggerated.
ADHD symptoms occur on a continuum and can fluctuate dramatically based on life circumstances such as transitions to middle school, stress levels and even sleep.
The new lung cancer screening program needs to be independently evaluated to keep it on track, and to minimise the harms.
A staggering rise in the prevalence of many medical conditions and the cultural attention we pay them is the subject of a new book, The Age of Diagnosis.
Experts challenge Streeting’s claim about ‘over-diagnosis’, and bring some nuance to the debate.
87% of posts mentioned the benefits of the tests, while only 15% mentioned potential harms.
Blanket screening Australians for skin cancer might lead to more diagnoses but not necessarily save more lives or be cost-effective.
We can’t isolate human misery from its broader context. But while adverse environments play a role in the youth mental health crisis, culture is crucial too.
If you’re aged 25 to 74, you might be due for a cervical cancer screening test. Here’s what to expect – and what’s changed in recent years.
Direct advertising of branded prescription drugs can lead patients to seek unnecessary medicines and treatments. Repealing the current law could help prevent this, and reduce health spending.
Women may be classed as high or low risk, and screened differently. But the path forward is not clear cut.
People who have a lower threshold for defining distress as a disorder are more likely to identify themselves as having a mental illness.
Having asymptomatic flat feet is not a problem and does not require treatment. It’s important to debunk this common myth.
Corporate medicine is hijacking feminist narratives around empowerment and women’s rights to market technologies, tests and treatments that aren’t backed by evidence.
Australia has among the highest antidepressant prescribing rates in the world.
Top contributors
-
Senior Research Manager, University of Sydney and Honorary Assistant Professor, Bond University
-
Professor of Clinical Epidemiology, Sydney School of Public Health, University of Sydney
-
Clinical Professorial Research Fellow, Australian Women and Girls' Health Research Centre, The University of Queensland
-
NHMRC Emerging Leader Research Fellow, School of Public Health, University of Sydney
-
Professor of Medicine, Bond University
-
Professor of Public Health, University of Sydney
-
Professor of Psychology, The University of Melbourne
-
Associate Professor, Bond University
-
Professor of Public Health, Bond University
-
Assistant Professor | NHMRC Emerging Leadership Fellow, Bond University
-
Professor School of Public Health and Preventive Medicine, Monash University
-
Emeritus Professor in Public Health, University of Sydney
-
Professor of Clinical Epidemiology, Bond University
-
Professor & Deputy Director, Women's Health Program, School of Public Health and Preventive Medicine, Monash University
-
NHMRC Emerging Leader Research Fellow in Reproductive Health, School of Public Health, University of Sydney